Publication:
Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions

dc.contributor.authorSalmas, Ramin Ekhteiari
dc.contributor.authorYurtsever, Mine
dc.contributor.authorStein, Matthias Jeanette
dc.contributor.authorDurdagi, Serdar
dc.contributor.institutionSalmas, Ramin Ekhteiari, Department of Chemistry, İstanbul Teknik Üniversitesi, Istanbul, Turkey
dc.contributor.institutionYurtsever, Mine, Department of Chemistry, İstanbul Teknik Üniversitesi, Istanbul, Turkey
dc.contributor.institutionStein, Matthias Jeanette, Molecular Simulations and Design Group, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany
dc.contributor.institutionDurdagi, Serdar, Molecular Simulations and Design Group, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany, Department of Biophysics, Bahçeşehir Üniversitesi, Istanbul, Turkey
dc.date.accessioned2025-10-05T16:32:07Z
dc.date.issued2015
dc.description.abstractHomology model structures of the dopamine D2 receptor (D2R) were generated starting from the active and inactive states of β2-adrenergic crystal structure templates. To the best of our knowledge, the active conformation of D2R was modeled for the first time in this study. The homology models are built and refined using MODELLER and ROSETTA programs. Top-ranked models have been validated with ligand docking simulations and in silico Alanine-scanning mutagenesis studies. The derived extra-cellular loop region of the protein models is directed toward the binding site cavity which is often involved in ligand binding. The binding sites of protein models were refined using induced fit docking to enable the side-chain refinement during ligand docking simulations. The derived models were then tested using molecular modeling techniques on several marketed drugs for schizophrenia. Alanine-scanning mutagenesis and molecular docking studies gave similar results for marketed drugs tested. We believe that these new D2 receptor models will be very useful for a better understanding of the mechanisms of action of drugs to be targeted to the binding sites of D2Rs and they will contribute significantly to drug design studies involving G-protein-coupled receptors in the future. © 2016 Elsevier B.V., All rights reserved.
dc.identifier.doi10.1007/s11030-015-9569-3
dc.identifier.endpage332
dc.identifier.issn13811991
dc.identifier.issn1573501X
dc.identifier.issue2
dc.identifier.pubmed25652238
dc.identifier.scopus2-s2.0-84939987863
dc.identifier.startpage321
dc.identifier.urihttps://doi.org/10.1007/s11030-015-9569-3
dc.identifier.urihttps://hdl.handle.net/20.500.14719/12763
dc.identifier.volume19
dc.language.isoen
dc.publisherKluwer Academic Publishers
dc.relation.sourceMolecular Diversity
dc.subject.authorkeywordsAlanine-scanning Mutagenesis
dc.subject.authorkeywordsDopamine D2 Receptor
dc.subject.authorkeywordsG-protein-coupled Receptors
dc.subject.authorkeywordsHomology Modeling
dc.subject.authorkeywordsMolecular Docking Simulations
dc.subject.authorkeywordsLigands
dc.subject.authorkeywordsReceptors, Dopamine D2
dc.subject.authorkeywordsDopamine 2 Receptor
dc.subject.authorkeywordsLigand
dc.subject.authorkeywordsProtein Binding
dc.subject.authorkeywordsAmino Acid Sequence
dc.subject.authorkeywordsChemical Phenomena
dc.subject.authorkeywordsChemical Structure
dc.subject.authorkeywordsChemistry
dc.subject.authorkeywordsConformation
dc.subject.authorkeywordsDrug Development
dc.subject.authorkeywordsGenetics
dc.subject.authorkeywordsHuman
dc.subject.authorkeywordsHydrogen Bond
dc.subject.authorkeywordsMetabolism
dc.subject.authorkeywordsMolecular Genetics
dc.subject.authorkeywordsProcedures
dc.subject.authorkeywordsProtein Engineering
dc.subject.authorkeywordsReproducibility
dc.subject.authorkeywordsSequence Alignment
dc.subject.authorkeywordsAmino Acid Sequence
dc.subject.authorkeywordsDrug Discovery
dc.subject.authorkeywordsHumans
dc.subject.authorkeywordsHydrogen Bonding
dc.subject.authorkeywordsHydrophobic And Hydrophilic Interactions
dc.subject.authorkeywordsLigands
dc.subject.authorkeywordsModels, Molecular
dc.subject.authorkeywordsMolecular Conformation
dc.subject.authorkeywordsMolecular Sequence Data
dc.subject.authorkeywordsMolecular Structure
dc.subject.authorkeywordsProtein Binding
dc.subject.authorkeywordsProtein Engineering
dc.subject.authorkeywordsReceptors, Dopamine D2
dc.subject.authorkeywordsReproducibility Of Results
dc.subject.authorkeywordsSequence Alignment
dc.subject.indexkeywordsdopamine 2 receptor
dc.subject.indexkeywordsligand
dc.subject.indexkeywordsprotein binding
dc.subject.indexkeywordsamino acid sequence
dc.subject.indexkeywordschemical phenomena
dc.subject.indexkeywordschemical structure
dc.subject.indexkeywordschemistry
dc.subject.indexkeywordsconformation
dc.subject.indexkeywordsdrug development
dc.subject.indexkeywordsgenetics
dc.subject.indexkeywordshuman
dc.subject.indexkeywordshydrogen bond
dc.subject.indexkeywordsmetabolism
dc.subject.indexkeywordsmolecular genetics
dc.subject.indexkeywordsprocedures
dc.subject.indexkeywordsprotein engineering
dc.subject.indexkeywordsreproducibility
dc.subject.indexkeywordssequence alignment
dc.subject.indexkeywordsAmino Acid Sequence
dc.subject.indexkeywordsDrug Discovery
dc.subject.indexkeywordsHumans
dc.subject.indexkeywordsHydrogen Bonding
dc.subject.indexkeywordsHydrophobic and Hydrophilic Interactions
dc.subject.indexkeywordsLigands
dc.subject.indexkeywordsModels, Molecular
dc.subject.indexkeywordsMolecular Conformation
dc.subject.indexkeywordsMolecular Sequence Data
dc.subject.indexkeywordsMolecular Structure
dc.subject.indexkeywordsProtein Binding
dc.subject.indexkeywordsProtein Engineering
dc.subject.indexkeywordsReceptors, Dopamine D2
dc.subject.indexkeywordsReproducibility of Results
dc.subject.indexkeywordsSequence Alignment
dc.titleModeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions
dc.typeArticle
dcterms.referencesRömpler, Holger, G protein-coupled time travel: Evolutionary aspects of GPCR research, Molecular Interventions, 7, 1, pp. 17-25, (2007), Congreve, Miles S., The impact of GPCR structures on pharmacology and structure-based drug design, British Journal of Pharmacology, 159, 5, pp. 986-996, (2010), Overington, John P., How many drug targets are there?, Nature Reviews Drug Discovery, 5, 12, pp. 993-996, (2006), Schiöth, Helgi Birgir, Structural diversity of g proteincoupled receptors and significance for drug discovery, Nature Reviews Drug Discovery, 7, 4, pp. 339-357, (2008), Rasmussen, Sǒren G.F., Crystal structure of the β 2 adrenergic receptor-Gs protein complex, Nature, 477, 7366, pp. 549-557, (2011), Jaakola, Veli Pekka, The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist, Science, 322, 5905, pp. 1211-1217, (2008), Haga, Kazuko, Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist, Nature, 482, 7386, pp. 547-551, (2012), Park, Jung-hee, Crystal structure of the ligand-free G-protein-coupled receptor opsin, Nature, 454, 7201, pp. 183-187, (2008), Scheerer, Patrick, Crystal structure of opsin in its G-protein-interacting conformation, Nature, 455, 7212, pp. 497-502, (2008), Jackson, David M., Dopamine receptors: Molecular biology, biochemistry and behavioural aspects, Pharmacology and Therapeutics, 64, 2, pp. 291-370, (1994)
dspace.entity.typePublication
local.indexed.atScopus
person.identifier.scopus-author-id56338023600
person.identifier.scopus-author-id56067383000
person.identifier.scopus-author-id7402996760
person.identifier.scopus-author-id22955598300

Files